AnalystsLuca IssiLuca Issi's Stock Forecasts
AnalystsLuca Issi
Sectors:
Industries:
Analyst Ranking
Top 11%
#553 out of 5342 analysts
Average Return
+11.32%
Win Rate
50%80 out of 161
Risk vs Reward
Poor
Good
Luca Issi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arrowhead Pharmaceuticals IncARWR | +445.62% | $16.42 | $89.59 | 2025-08-08 - 2026-08-04 | Buy |
Uniqure NvQURE | +263.97% | $7.16 | $26.06 | 2024-11-06 - 2025-11-05 | Buy |
Arrowhead Pharmaceuticals IncARWR | +233.09% | $18.89 | $62.92 | 2025-02-11 - 2026-02-10 | Buy |
Dyne Therapeutics IncDYN | +181.52% | $9.20 | $25.90 | 2025-07-29 - 2026-07-28 | Buy |
Ionis Pharmaceuticals IncIONS | +154.34% | $32.69 | $83.15 | 2025-02-20 - 2026-02-19 | Buy |
Luca Issi Analyst Color
Get additional color on Luca Issi's coverage of popular stocks
Luca Issi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals IncALNY | 30 | Buy | $350.00 | +59.82% | Maintains | 5 days ago |
Dyne Therapeutics IncDYN | 5 | Buy | $35.00 | +34.77% | Maintains | 6 days ago |
Argenx SeARGX | 6 | Buy | $1,025.00 | +21.37% | Maintains | 12 days ago |
Ionis Pharmaceuticals IncIONS | 13 | Buy | $85.00 | +54.35% | Maintains | 24 days ago |
Ultragenyx Pharmaceutical IncRARE | 4 | Buy | $40.00 | +54.98% | Maintains | a month ago |
Moderna IncMRNA | 21 | Hold | $45.00 | -21.04% | Maintains | a month ago |
Biomarin Pharmaceutical IncBMRN | 14 | Hold | $62.00 | +2.11% | Maintains | a month ago |
Ascendis Pharma AASND | 6 | Buy | $280.00 | +14.48% | Maintains | a month ago |
Agios Pharmaceuticals IncAGIO | 2 | Hold | $32.00 | +1.27% | Maintains | a month ago |
Uniqure NvQURE | 9 | Buy | $65.00 | +48.81% | Maintains | 2 months ago |
Arrowhead Pharmaceuticals IncARWR | 12 | Buy | $87.00 | -2.89% | Maintains | 3 months ago |
Bridgebio Pharma IncBBIO | 1 | Buy | $100.00 | +21.85% | Initiates Coverage On | 4 months ago |
Intellia Therapeutics IncNTLA | 8 | Hold | $15.00 | +32.51% | Maintains | 5 months ago |
Beam Therapeutics IncBEAM | 8 | Hold | $26.00 | -8.29% | Maintains | 5 months ago |
Wave Life Sciences LtdWVE | 6 | Buy | $27.00 | +350.00% | Upgrades | 8 months ago |
Fulcrum Therapeutics IncFULC | 3 | Hold | $10.00 | +163.16% | Maintains | 8 months ago |
Korro Bio IncKRRO | 8 | Hold | $8.00 | -29.52% | Downgrades | 9 months ago |
Crispr Therapeutics AgCRSP | 14 | Hold | $50.00 | -5.78% | Maintains | 9 months ago |
Regenxbio IncRGNX | 10 | Buy | $19.00 | +84.47% | Maintains | 9 months ago |
Avidity Biosciences IncRNAM | 3 | Hold | $72.00 | +388.14% | Downgrades | 9 months ago |
Adverum Biotechnologies IncADVM | 8 | Hold | $4.00 | N/A | Maintains | a year ago |
Allogene Therapeutics IncALLO | 8 | Buy | $10.00 | N/A | Reiterates | a year ago |
Apellis Pharmaceuticals IncAPLS | 7 | Hold | $18.00 | N/A | Maintains | a year ago |
Lexeo Therapeutics IncLXEO | 5 | Buy | $20.00 | N/A | Maintains | a year ago |
Sangamo Therapeutics IncSGMO | 6 | Hold | $2.00 | N/A | Reiterates | a year ago |
Ocular Therapeutix IncOCUL | 1 | Buy | $17.00 | N/A | Initiates Coverage On | a year ago |
Meiragtx Holdings PLCMGTX | 6 | Buy | $13.00 | N/A | Maintains | a year ago |
Verve Therapeutics IncVERV | 7 | Buy | $15.00 | N/A | Maintains | a year ago |
4d Molecular Therapeutics IncFDMT | 7 | Buy | $35.00 | N/A | Maintains | a year ago |
Slb LimitedSLB | 1 | Buy | $57.00 | N/A | Reiterates | 2 years ago |
Editas Medicine IncEDIT | 8 | Hold | $4.00 | N/A | Maintains | 2 years ago |
Bluebird Bio IncBLUE | 4 | Hold | $80.00 | N/A | Reiterates | 2 years ago |
Caribou Biosciences IncCRBU | 5 | Buy | $14.00 | N/A | Reiterates | 2 years ago |
Lenz Therapeutics IncLENZ | 3 | Hold | $3.00 | N/A | Maintains | 3 years ago |
Q32 Bio IncQTTB | 3 | Hold | $54.00 | N/A | Maintains | 4 years ago |
Dicerna Pharmaceuticals IncDRNA | 2 | Hold | $38.25 | N/A | Downgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.